- Email:
STEMOD™ Neuroscience Ex Vivo Model Services
Introduction
Translational neuroscience is hindered by the translational gap between animal models and human outcomes. Supported by recent research, 3D organoids and ex vivo models better simulate human CNS pathologies. Creative Biolabs' STEMOD™ platform combines microfluidics and iPSC technology to establish human-derived ex vivo models, including organoid-on-chip and organotypic brain slices. We provide accurate data on drug permeability, neurotoxicity, and efficacy, reduce species differences, and improve clinical predictability to accelerate drug discovery.
Discover How We Can Help - Request a Consultation →
Neuroscience Ex Vivo Model Services
Neuroscience ex vivo models serve as a critical bridge between in vitro assays and in vivo studies, enabling high-precision, human-relevant research in neural development, disease mechanisms, and drug evaluation. Creative Biolabs provides a full suite of customizable ex vivo modeling solutions derived from iPSCs or primary tissues, with strict quality control to ensure physiological fidelity, functional maturity, and experimental reproducibility.
Fig.1
Schematic illustration of the state-of-the-art materials, techniques, and models for lab-on-chip microsystem-based ex vivo NoN studies.1
Key Applications
- Custom Brain Spheroid: Stable, scalable 3D neural models for high-throughput drug screening, cytotoxicity testing, and early neural development research.
- Custom Brain Organoid: Region-specific or whole-brain organoids that recapitulate neural structures, circuits, and activities for disease mechanism and therapeutic testing.
- Custom CNS Disease Modeling: Patient-specific or gene-edited ex vivo models for neurodegenerative, neuropsychiatric, and neurodevelopmental disorder research.
- Blood-Brain Barrier Model: Functional BBB models with tight junctions and transporter activity to study drug penetration, neuroinflammation, and CNS delivery.
- Custom Neural Differentiation: Directed differentiation into neurons, astrocytes, oligodendrocytes, and other neural lineages for cell function, electrophysiology, and transcriptomic studies.
Key Advantages
- Fully customizable models tailored to research goals and experimental design
- Human-derived systems with higher clinical relevance than animal models
- Compatible with imaging, electrophysiology, omics, and drug screening platforms
- Stable performance, low batch variation, and robust data output
Workflow
To initiate the service, clients typically provide Required Starting Materials such as specific genetic sequences for CRISPR/Cas9 modification, target compound profiles for neurotoxicity testing, or patient-derived iPSC lines (though Creative Biolabs can also provide standardized wild-type or disease-model cell lines).
What We Can Offer
Creative Biolabs delivers a suite of customized solutions tailored to your specific CNS drug discovery objectives. Our STEMOD™ Neuroscience Ex Vivo Model services include:
Customized 3D Neural Architecture
Precise development of region-specific organoids (forebrain, midbrain, hippocampal) tailored to your target pathology;
Integrated Multi-Modal Sensing
Real-time monitoring via high-density Microelectrode Arrays (MEAs) to capture network-level electrophysiological signatures;
Advanced Microfluidic Perfusion
Implementation of automated media exchange systems to maintain optimal nutrient gradients and prevent core necrosis in thick 3D tissues;
Precision Genetic Engineering
One-stop CRISPR/Cas9 services for the creation of patient-specific disease models or reporter cell lines;
High-Throughput Neurotoxicity Screening
Scalable organoid-on-chip platforms capable of evaluating safety profiles for hundreds of compounds simultaneously;
Validated BBB Penetration Assays
Co-culture models incorporating human brain microvascular endothelial cells, pericytes, and astrocytes for accurate drug-permeability assessment;
All-side Data Interpretation
Detailed computational analysis of synaptic plasticity, calcium signaling, and morphological changes following compound exposure.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Customer Reviews
FAQs
Q: How does STEMOD™ compare to traditional rodent brain slices?
A: Rodent models often lack human-specific gene expressions and proliferative zones. STEMOD™ uses human-derived iPSCs or validated ex vivo human tissue, providing data that is directly applicable to human clinical outcomes without the "species gap."
Q: Can you model specific genetic mutations?
A: Yes, we frequently use gene editing tools to create custom disease models, such as inserting APOE4 for Alzheimer's studies or LRRK2 for Parkinson's research, allowing for precise mechanistic studies.
Q: What prevents the organoids from dying in the center?
A: We utilize advanced microfluidic perfusion systems that mimic vascular flow. This ensures that oxygen and nutrients reach the core of the 3D structure, allowing for long-term viability and more mature development.
Q: Is this model suitable for high-throughput screening?
A: Yes. Our lab-on-chip microsystems are designed for scalability, allowing us to screen large libraries of neuroactive molecules with high efficiency and minimal reagent volume.
Q: How long can these cultures be maintained?
A: While standard cultures degrade quickly, our organotypic slice and organoid-on-chip systems can be maintained for several weeks to months, making them ideal for chronic toxicity and progressive neurodegeneration studies.
Creative Biolabs offers the industry's most full-scale suite of STEMOD™ Neuroscience Ex Vivo Models, providing a bridge from benchtop discovery to clinical success. Our unique synergy of 3D biology and microfluidic engineering ensures your neuro-therapeutic candidates are tested in the most realistic environment possible.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Zhang, Hongyong, et al. "Lab-on-chip microsystems for ex vivo network of neurons studies: A review." Frontiers in Bioengineering and Biotechnology 10 (2022): 841389. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fbioe.2022.841389.
For Research Use Only. Not For Clinical Use.